Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure

* VYNDAMAX has been listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM)with New York Heart Association (NYHA) Class I-II heart failure.[1] * ATTR-CM is a debilitating and often fatal condition that l...

2024-05-04 18:00 746

United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024

Ultra-high-field technology, ultra-high-gradient technology, and advances in artificial intelligence take center stage. SHANGHAI, May 4, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technolog...

2024-05-04 09:00 1157

Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success

Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics LONDON, May 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announ...

2024-05-02 15:00 1135

Vivo Surgical Announces Leading Gastrointestinal Endoscopists on Clinical Advisory Board for Novel Endoscopic Robot

Inaugural international clinical advisory board to provide strategic guidance towards development of the company's ERES™ endoscopic robot SINGAPORE, May 2, 2024 /PRNewswire/ -- Vivo Surgical Private Limited, a privately-held surgical technology company pioneering a flexible endoscopic robot for ...

2024-05-02 10:00 1379

Vivo Surgical Announces Leading Gastrointestinal Endoscopists on Clinical Advisory Board for Novel Endoscopic Robot

Everest Medicines Announces Hong Kong Department of Health Approval of Nefecon® for the Treatment for Primary IgA Nephropathy in Adult Patients

SHANGHAI, May 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced that the Hong Kong Department of Health had approved Nefecon® for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression.Hong Kong marks the...

2024-05-02 09:23 1600

United Imaging Receives FDA Clearance for Breakthrough 5T MRI System

As the company heads to ISMRM, the world's first whole-body Ultra-High Field MRI officially comes to market. HOUSTON, May 2, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has achieved a significant milestone with the U....

2024-05-02 03:00 1003

3Shape Unveils Unite 3rd Generation: Access TRIOS Scans Anywhere, Anytime

COPENHAGEN, Denmark, May 1, 2024 /PRNewswire/ -- 3Shape launches Unite 3rd Generation, allowing dental professionals to access and work with their digital impressions and patient cases anywhere, anytime, via any mobile, tablet (Android, iOS), or web device. This update enables seamless and secure...

2024-05-01 21:43 990

Neogen® Petrifilm® Celebrates 40 Years!

LANSING, Mich., May 1, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) is celebrating 40 years of Petrifilm, the innovation that changed how microbiologists around the world perform indicator testing. "In the food safety industry, Petrifilm is recognized as a true game-changer," saidJohn...

2024-05-01 20:45 1289

ArisGlobal Helps Boehringer Ingelheim Transform Safety Signal Processing by Leveraging Latest LifeSphere Solutions

LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim's pharmaceutical operations approach safety signals BOSTON, May 1, 2024 /PRNewswire/ -- ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, announced today that research-driven g...

2024-05-01 20:00 1188

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 1, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimula...

2024-05-01 08:01 1354

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

* The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance * Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unifiedplatform for efficient global commerciali...

2024-04-30 19:00 1988

BiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay Healthy

Herbalmeds partners with Watsons Malaysia to launch a series of sleep-focused consumer engagement activities KUALA LUMPUR, Malaysia, April 30, 2024 /PRNewswire/ -- With 9 out of 10 Malaysians experiencing some form of sleep disorder[1], getting sufficient and quality sleep has become an elusive...

2024-04-30 16:11 1070

BiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay Healthy

BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report

Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the ...

2024-04-30 15:00 921

Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)

SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...

2024-04-30 12:30 1661

Chang Gung Memorial Hospital, Linkou, Garners Two Prestigious International Awards for Its Outstanding Achievements

The hospital honored with Hospital of the Year - Taiwan and Smart Hospital Initiative of the Year -Taiwan at the Healthcare Asia Awards TAOYUAN, April 30, 2024 /PRNewswire/ -- The Healthcare Asia Awards, a prestigious international recognition program, honors exceptional healthcare institutions ...

2024-04-30 09:03 1018

Chang Gung Memorial Hospital, Linkou, Garners Two Prestigious International Awards for Its Outstanding Achievements

Henlius Trastuzumab Receives FDA Approval in the United States

SHANGHAI, April 29, 2024 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner, Accord BioPharma Inc. (the U.S. specialty division of Intas Pharmaceuticals, Ltd.), has received approval from the United States Food and Drug Administration (FDA) for ...

2024-04-29 20:18 1880

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

GAITHERSBURG, Md., April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-29 20:00 1122

INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics

Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommendations CAMBRIDGE, Mass., April 29, 2024 /PRNewswire/ -- Building on its commitment to identify strengths and gaps in the R&D pipeline for ant...

2024-04-29 12:00 1063

Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome

CASTRES, France, April 26, 2024 /PRNewswire/ -- Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSA™ (vibegron under the international non-propriet...

2024-04-26 23:46 2085

United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%

Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report. SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, h...

2024-04-26 23:00 1743

12 3 4 5 ... 383